Nav1.7 antisense oligonucleotide (Quiver Bioscience)

N/A

Report date: 2025/06/27 16:57:42
NME

Base Information

Drug NameNav1.7 antisense oligonucleotide (Quiver Bioscience)
Drug Alias NameNav1.7 (ASO)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies +[1]  N/A
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A